PHARMACOKINETICS AND SAFETY OF ONCE DAILY DOUBLE DOSE INHALED TOBRAMYCIN ADMINISTERED WITH CCONTROLLED-INHALATION AND JET-NEBULIZER IN CYSTIC FIBROSIS

被引：0
|
作者：
Bos, Aukje [1 ,2 ]
van Velzen, A. J. [3 ]
Touw, D. J. [4 ,5 ]
Tiddens, H. A. W. M. [1 ,2 ]
Heijerman, H. G. M. [6 ]
Janssens, H. M. [1 ]
机构：
[1] Erasmus MC Sophia Childrens Hosp, Dept Pediat Pulmonol & Allergol, Rotterdam, Netherlands
[2] Erasmus MC, Dept Pediat Radiol, Rotterdam, Netherlands
[3] Cent Hosp Pharm, Miami, FL USA
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, NL-9700 AB Groningen, Netherlands
[5] Univ Groningen, Guide Farmacokinet Toxicol & Targeting, NL-9700 AB Groningen, Netherlands
[6] Haga Teaching Hosp, Dept Pulmonol, The Hague, Netherlands
来源：
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY | 2015年 / 28卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P-121
引用
收藏
页码：A5 / A6
页数：2
相关论文
共 40 条
  • [1] Pharmacokinetics and Tolerability of Once Daily Double Dose Tobramycin Inhalation in Cystic Fibrosis Using Controlled and Conventional Nebulization
    van Velzen, A. J.
    Bos, A. C.
    Touw, D. J.
    Tiddens, H. A. W. M.
    Heijerman, H. G. M.
    Janssens, H. M.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2016, 29 (03) : 273 - 280
  • [2] Pharmacokinetics and safety of tobramycin administered by the PARI eFlow® rapid nebulizer in cystic fibrosis
    Hubert, Dominique
    Leroy, Sylvie
    Nove-Josserand, Raphaele
    Murris-Espin, Marlene
    Mely, Laurent
    Dominique, Stephane
    Delaisi, Bertrand
    Kho, Pearl
    Kovarik, John M.
    JOURNAL OF CYSTIC FIBROSIS, 2009, 8 (05) : 332 - 337
  • [3] Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis
    Touw, D. J.
    Knox, A. J.
    Smyth, A.
    JOURNAL OF CYSTIC FIBROSIS, 2007, 6 (05) : 327 - 333
  • [4] Pharmacokinetics of comparison of once daily tobramycin or thrice daily dose in cystic fibrosis patients
    Canis, F
    Trivier, D
    Vic, P
    Ategbo, S
    Turck, D
    Husson, MO
    PATHOLOGIE BIOLOGIE, 1998, 46 (06): : 449 - 451
  • [5] Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis
    Bates, RD
    Nahata, MC
    Jones, JW
    McCoy, K
    Young, G
    Cox, S
    Barson, WJ
    CHEST, 1997, 112 (05) : 1208 - 1213
  • [6] Pharmacokinetics and safety of an 8 week continuous treatment with once-daily versus twice-daily inhalation of tobramycin in cystic fibrosis patients
    van Koningsbruggen-Rietschel, S.
    Heuer, H. E.
    Merkel, N.
    Posselt, H. G.
    Staab, D.
    Sieder, C.
    Ziegler, J.
    Krippner, F.
    Rietschel, E.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (03) : 711 - 717
  • [7] Inhalation of tobramycin in cystic fibrosis - Part 2. Optimization of the tobramycin solution for a jet and an ultrasonic nebulizer
    Le Brun, PPH
    de Boer, AH
    Gjaltema, D
    Hagedoorn, P
    Heijerman, HGM
    Frijlink, HW
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 189 (02) : 215 - 225
  • [8] PHARMACOKINETICS AND TOLERABILITY IN CYSTIC FIBROSIS OF DOUBLE DOSE NEBULIZED TOBRAMYCIN USING CONTROLLED AND CONVENTIONAL INHALATION
    Bos, A. C.
    van Velzen, A. J.
    Touw, D. J.
    Tiddens, H.
    Heijerman, H. G.
    Janssens, H. M.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 326 - 326
  • [9] Pharmacokinetics of once-daily versus thrice daily tobramycin in cystic fibrosis patients
    Guglielmo, BJ
    Quan, LA
    Stulbarg, MS
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (05) : 1040 - 1042
  • [10] Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety
    Geller, David E.
    Konstan, Michael W.
    Smith, Jeffrey
    Noonberg, Sarah B.
    Conrad, Carol
    PEDIATRIC PULMONOLOGY, 2007, 42 (04) : 307 - 313
1234